Day: January 27, 2026

Press Release         Atos Named as a Leader in the ISG Provider Lens™ for AI-Driven Application Managed Services and Application Development Outsourcing Paris, France, January 27, 2026 – Atos, a global leader in AI-powered digital transformation, has been named by Information Services Group (ISG), the leading global research and advisory firm as a Leader in European AI-Driven Application Managed Services, and AI-Driven Application Development Outsourcing.  This comprehensive vendor assessment covered 29 Service Providers, with Atos sharing the top Leader ranking with vendors such as Accenture, Capgemini, and Deloitte.  The report highlights the rapid evolution of GenAI as the foundation of next-generation ADM services, where leading vendors such as Atos are successfully embedding capabilities like the Atos Polaris AI Platform to...

CAMBRIDGE, Mass., Jan. 27, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it has been selected as one of only ten companies worldwide to participate in the Japan Entry Acceleration Program (JEAP), a highly competitive initiative launched by the Japan External Trade Organization (JETRO). JEAP drew approximately 70 regenerative medicine companies from 25 countries, underscoring the competitiveness of the selection process. Ernexa was chosen for its differentiated cell therapy platform and its potential to contribute meaningfully to Japan’s globally recognized regenerative medicine and oncology ecosystem. Notably, six of the ten selected companies focus on oncology, placing Ernexa among an...

Key Milestone Builds Toward Doubling Patent Portfolio to Over 200 Worldwide – Positioning Propanc as a Long-Term Leader in Metastatic Cancer Prevention MELBOURNE, Australia, Jan. 27, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and metastatic cancer, today announced the filing of its fourth new provisional patent application in the past two months with IP Australia. This latest application focuses on innovative formulations of the pancreatic proenzymes, trypsinogen and chymotrypsinogen— the active components in Propanc’s lead asset, PRP — addressing critical challenges in stability, storage, freeze/thaw cycling, and global transport. These advancements overcome longstanding...

MLPI and smart zone management strengthen mobility across large campus sites SALT LAKE CITY, Jan. 27, 2026 (GLOBE NEWSWIRE) — OMNIQ CORP (OTCMKTS: OMQS) (“OMNIQ” or “the Company”), a leader in AI-based computer vision and data intelligence, has been contracted to provide LPR solutions for a major technology innovator. The customer is one of the world’s most influential technology companies, supported by tens of thousands of employees across the broader Silicon Valley region. Its sprawling campuses require reliable, efficient, and highly secure mobility and access solutions. The company is deploying OMNIQ LPR technology across multiple campuses to support a more efficient and secure mobility experience. The solution includes MLPI, the mobile AI-based license plate inventory system that gives the customer real-time visibility across...

TEL AVIV, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — HUB Cyber Security Ltd. (Nasdaq: HUBC) (“HUB” or the “Company”), a global leader in confidential computing and secured data fabric technologies, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is currently not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum Market Value of Listed Securities of US$35 million (“MVLS”) for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”). This press release is issued pursuant to Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification. The notification has no immediate effect on the listing of the Company’s ordinary shares, which will continue to trade uninterrupted...

The success of the development phase moves the technology to operational product deployment Rehovot, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — Maris-Tech Ltd. (Nasdaq: MTEK, MTEKW) (“Maris-Tech” or the “Company”), a global leader in video and artificial intelligence (“AI”) – based edge computing technology, today announced it has received a follow-on purchase order for the supply of intelligence gathering operational products, scheduled for delivery during the second quarter of 2026. The order follows the successful completion of an earlier product development engagement, during which Maris-Tech worked closely with the customer to design, refine, and mature specialized technologies for intelligence gathering applications. With development milestones achieved and validated, the customer has now transitioned the engagement...

Kfar Saba, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the signing of a new reseller agreement with a prominent Western European partner. The agreement includes an initial purchase order for DefendAir training kits, marking another step in ParaZero’s strategic expansion throughout Europe, particularly within major NATO-aligned defense markets. This latest reseller partnership builds on ParaZero’s recent successes in the region, including a strategic distribution agreement with a leading Western European distributor, successful live demonstrations of the DefendAir platform for senior NATO officers from...

Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers NEW YORK and SACRAMENTO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced that it has partnered with Alpha Aesthetic Partners for the Aesthetics Leadership with Obagi‘s Hyaluronic Acid (ALOHA) Program. Alpha was selected as an ALOHA launch partner for its demonstrated commitment to innovation, education, collaboration, and advancing aesthetic medicine through scalable, high-quality care models. Through this real-world evaluation collaboration, Alpha will conduct a structured, multi-site evaluation of Obagi® saypha® MagIQ™...

Company to Centralize AI, Data, Capital Allocation, and Governance, Enabling Modular Expansion Across Its Portfolio KUALA LUMPUR, Malaysia, Jan. 27, 2026 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”) today announced a strategic transformation into an AI-native platform, repositioning the Company to enhance scalability, capital efficiency, and execution discipline across its portfolio of businesses. Under the new model, VCI Global will operate as a centralized AI-driven platform, with subsidiaries, affiliates, and portfolio companies structured as modular business units that “plug into” shared AI infrastructure, standardized data and KPIs, and centralized capital and governance frameworks. This shift represents a fundamental evolution in how the Company governs, scales, and optimizes its operations. From...